In early 2026, Moderna reported encouraging long-term data for its personalized cancer vaccine mRNA-4157 (V940) in high-risk ...
Flu is surging across most of the U.S. But, amid an early, harsh season, there is a glimmer of promising news: The flu shot may be more effective than experts predicted. Early evidence shows that this ...
Every year, flu vaccines are updated to match the flu viruses expected to circulate. For 2026, the vaccine focuses on several influenza strains that research predicts will be most prevalent. This ...